Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis

BACKGROUND: Most minimal residual disease-directed treatment interventions in current treatment protocols for acute lymphoblastic leukemia are based on bone marrow testing, which is a consequence of previous studies showing the superiority of bone marrow over peripheral blood as an investigational m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Volejnikova, Jana, Mejstrikova, Ester, Valova, Tatana, Reznickova, Leona, Hodonska, Ladislava, Mihal, Vladimir, Sterba, Jaroslav, Jabali, Yahia, Prochazkova, Daniela, Blazek, Bohumir, Hak, Jiri, Cerna, Zdenka, Hrusak, Ondrej, Stary, Jan, Trka, Jan, Fronkova, Eva
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2011
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232264/
https://ncbi.nlm.nih.gov/pubmed/21880630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.042937
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados